
In China, a revolutionary cancer drug called Sunvozertinib has become a lifeline for several foreign patients. Debbie Doppelt, a woman from New York, was diagnosed with a rare gene-mutated non-small cell lung cancer in 2023.
While a film depicted Chinese cancer patients traveling to India for affordable generic drugs, an American woman with late-stage lung cancer was able to extend her life by 19 months after taking a revolutionary Chinese cancer drug, sunvozertinib. Her son discovered the drug at a lung cancer conference, where it was still in clinical trials in the United States but had already received market approval in China by August 2023.

In China, a revolutionary cancer drug called Sunvozertinib has become a lifeline for several foreign patients. Debbie Doppelt, a woman from New York, was diagnosed with a rare gene-mutated non-small cell lung cancer in 2023.